" class="no-js "lang="en-US"> Ori Biotech Raises Over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform - Medtech Alert
Saturday, June 10, 2023

Ori Biotech Raises Over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform

Companies In This Post

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more